Clinical Trial Update: Late Phase II Study of TS-142 in Patients with Insomnia [Phase 2]

View source ↗

Summary

Taisho's TS-142 has completed a Phase II trial in patients with insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• TS-142

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Patients with Insomnia | Phase 2 | Status: COMPLETED